InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by MOEBIUS HANS, Directeur Médical. Insider active across 1 company, notably Athira Pharma, Inc.. Cumulatively, 11 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €43k. Activity tracked since 18 May 2021. The latest transaction was filed on 4 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
10,000 shares0Common StockSEC:0001209191-24-001157:0
7,764 shares@ US$2.4110.9% of flowCommon StockSEC:0001209191-23-034886:0
7,882 shares@ US$1.356.2% of flowCommon StockSEC:0001209191-23-034886:1
5,000 shares@ US$3.288410.0% of flowCommon StockSEC:0001209191-22-057721:0
Ideal exit: 12 Aug 2023 (T+270)
7,881 shares@ US$1.356.8% of flowCommon StockSEC:0001209191-22-053869:0
10,000 shares@ US$2.8825.9% of flowCommon StockSEC:0001209191-22-039937:0
Ideal exit: 25 Mar 2023 (T+270)
1,699 shares@ US$7.0610.8% of flowCommon StockSEC:0001209191-22-039343:0
829 shares@ US$12.518.7% of flowCommon StockSEC:0001209191-22-004120:0
829 shares@ US$12.515.7% of flowCommon StockSEC:0001209191-22-004120
2,055 shares@ US$14.4515.2% of flowCommon StockSEC:0001209191-21-047601
2,055 shares@ US$14.4523.0% of flowCommon StockSEC:0001209191-21-047601:0
11 of 11 declarations
About MOEBIUS HANS
MOEBIUS HANS is Chief Medical Officer at Athira Pharma, Inc. In this role, he is responsible for medical strategy and overseeing clinical activities. His expertise in medicine and clinical research enables him to contribute to innovation and treatment improvement. Hans is committed to supporting Athira Pharma's mission of enhancing patients' lives.
